Page 59 - HIV/AIDS Guidelines

111.Palella FJ, Jr., Gange SJ, Benning L, et al. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV
Study and the Multicenter AIDS Cohort Study. AIDS. Jul 17 2010;24(11):1657-1665.
112.Rodger AJ, Fox Z, Lundgren JD, et al. Activation and coagulation biomarkers are independent predictors of the
development of opportunistic disease in patients with HIV infection. J Infect Dis. Sep 15 2009;200(6):973-983.
113.Centers for Disease Control and Prevention (CDC). Achievements in public health. Reduction in perinatal transmission
of HIV infection--United States, 1985-2005. MMWR Morb Mortal Wkly Rep. Jun 2 2006;55(21):592-597.
114.Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for
Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV Transmission in the United States, Sep. 14, 2011; pp 1-207. Available at
http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf. 2011.
115.Vernazza PL, Troiani L, Flepp MJ, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the
seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS. Jan 28 2000;14(2):117-121.
116.Coombs RW, Reichelderfer PS, Landay AL. Recent observations on HIV type-1 infection in the genital tract of men and
women. AIDS. Mar 7 2003;17(4):455-480.
117.Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency
virus type 1. Rakai Project Study Group. N Engl J Med. Mar 30 2000;342(13):921-929.
118.Tovanabutra S, Robison V, Wongtrakul J, et al. Male viral load and heterosexual transmission of HIV-1 subtype E in
northern Thailand. J Acquir Immune Defic Syndr. Mar 1 2002;29(3):275-283.

119.Kayitenkore K, Bekan B, Rufagari J, et al. The impact of ART on HIV transmission among HIV serodiscordant couples.
16th International AIDS Conference. Aug. 13-18 2006; Toronto, Canada.

120.Reynolds S, Makumbi F, Nakigozi G, et al. HIV-1 transmission among HIV-1 discordant couples before and after the
introduction of antiretroviral therapy. AIDS. Feb 20 2011;25(4):437-7.

121.Sullivan P, Kayitenkore K, Chomba E, al. e. Reduction of HIV transmission risk and high risk sex while prescribed ART:
Results from discordant couples in Rwanda and Zambia. Paper presented at 16th Conference on Retroviruses and
Opportunistic Infections (CROI): Feb. 8-11 2009; Montreal, Canada.
122.Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate
antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. Jan 3
2009;373(9657):48-57.
123.Bunnell R, Ekwaru JP, Solberg P, et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral
therapy and prevention interventions in rural Uganda. AIDS. Jan 2 2006;20(1):85-92.
124.Castilla J, Del Romero J, Hernando V, Marincovich B, Garcia S, Rodriguez C. Effectiveness of highly active antiretroviral
therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. Sep 1 2005;40(1):96-101.
125.Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a
model-based analysis. Lancet. Jul 26 2008;372(9635):314-320.

126.Worm SW, Sabin C, Weber R, et al. Risk of myocardial infarction in patients with HIV infection exposed to specific
individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs
(D:A:D) study. J Infect Dis. Feb 1 2010;201(3):318-330.
127.Freedberg KA, Losina E, Weinstein MC, et al. The cost effectiveness of combination antiretroviral therapy for HIV
disease. N Engl J Med. Mar 15 2001;344(11):824-831.
128.Schackman BR, Goldie SJ, Weinstein MC, Losina E, Zhang H, Freedberg KA. Cost-effectiveness of earlier initiation of
antiretroviral therapy for uninsured HIV-infected adults. Am J Public Health. Sep 2001;91(9):1456-1463.
129.Mauskopf J, Kitahata M, Kauf T, Richter A, Tolson J. HIV antiretroviral treatment: early versus later. J Acquir Immune
Defic Syndr. Aug 15 2005;39(5):562-569.

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents E-18

Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.